Malignancy treatment benefits from a strong synergistic effect when T-1 therapy is combined with chemotherapy, leading to enhanced anti-tumor immune responses. The pleiotropic effects of T-1 on immune cells, combined with the promising results from preclinical studies, suggest that T-1 may be a ...